Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...

Young adults with high social anxiety show heightened activity in the brain's visual processing areas. These neural changes explain their high alertness to social threats and offer a physical marker ...

"AtaiBeckley’s MDMA-based drug for anxiety shows benefit in Phase IIa trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder March 5, 2026 7:30 AM ESTCompany ParticipantsMichael Cola - ...

Analysts consider AtaiBeckley’s MDMA candidate a “high-risk, high-reward” bet after the drug demonstrated reductions in ...

Low choline levels in the brain are associated with anxiety disorders, research has found. Experts explain what choline is ...

Tomorrow is election day, and for many it is a day of intense anxiety. And with poliitical turmoil surrounding the globe, the ...

Anxiety disorders are common. However, anxiety can also be a symptom of a general medical disorder or a side effect of a medication. Those cases must be identified promptly.

The latest announcement is out from Cybin ( (HELP) ).

Helus Pharma HELP shares are down on Thursday following the announcement of topline results from a Phase 2 signal detection study for HLP004, a potential treatment for generalized anxiety disorder ...

A neuroimaging study published in Psychiatry Research: Neuroimaging has identified hyperactivity in the superior occipital ...